Cov-N-Psy

Belgium
|
2021-2024
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

Yildiz

Türkiye
|
2021-2023
  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

COMEBAC 2

France
|
2021-2022
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

Andreasson

Sweden
|
2021-2025
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Community
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample

Bridevaux

Switzerland
|
2021-2022
  • Adults
  • Elderly
  • Paediatric
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

Aguilaniu

Canada | France | Martinique| Switzerland
|
2022-2023
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

DisCOVID

France
|
2021-2024
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

FAPI CLIMATE

Netherlands
|
2022-2024
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample

Orth

Germany
|
2022-2023
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Monoclonal antibodies
  • Sotrovimab
  • Molnupiravir
  • Tixagevimab/Cilgavimab
  • Casirivimab/Imdevimab

Cuadrado-Payán

Spain
|
2021-2022
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • Outpatient clinic
  • Community
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir

Gentile

Italy
|
2023-2023
  • Adults
  • Elderly
  • Fragile population
  • Immunocompromised host
  • Hospital wide
  • Infectious diseases unit
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Nirmatrelvir/Ritonavir
  • Remdesivir
  • Monoclonal antibodies
  • Sotrovimab

Ferro

Italy
|
2020-2022
  • Adults
  • Elderly
  • Fragile population
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Pharmacological intervention
  • Antivirals
  • Remdesivir
  • Immnunomodulator
  • Steroids
  • Baricitinib
  • Dexamethasone
  • Methylprednisolone